Baker Bros. Advisors LP 13D and 13G filings for Talis Biomedical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-10 4:55 pm Purchase | 2023-03-10 | 13D | Talis Biomedical Corporation TLIS | Baker Bros. Advisors LP | 2,505,086 66.200% | 4,750 (+0.19%) | Filing |
| 2022-06-13 5:27 pm Purchase | 2022-06-07 | 13D | Talis Biomedical Corporation TLIS | Baker Bros. Advisors LP | 2,500,336 66.400% | 4,389 (+0.18%) | Filing |
| 2021-04-02 4:01 pm Unchanged | 2021-03-26 | 13D | Talis Biomedical Corporation TLIS | Baker Bros. Advisors LP | 2,495,947 67.500% | 0 (Unchanged) | Filing |
| 2021-02-26 4:52 pm Purchase | 2021-02-17 | 13D | Talis Biomedical Corporation TLIS | Baker Bros. Advisors LP | 2,495,947 67.600% | 2,495,947 (New Position) | Filing |